Picture of Taysha Gene Therapies logo

TSHA Taysha Gene Therapies Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Taysha Gene Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments25114987.9144
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.01525816096.4150
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.28750.625.920.4
Other Long Term Assets
Total Assets0.015259214126173
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.157.1351.762.836.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.157.5811912597.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.13525195.40.94974.9
Total Liabilities & Shareholders' Equity0.015259214126173
Total Common Shares Outstanding